Mammalian interleukin-4
US5017691A · kind A · utility
151Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 1986 |
| Grant date | May 21, 1991 |
| Priority date | — |
| Expiry date | Sep 17, 2006 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16243
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Mammalian proteins and muteins thereof, designated interleukin-4s (IL-4s), are provided which exhibit both B cell growth factor activity and T cell growth factor activity. Compounds of the invention include native human and murine IL-4s, muteins thereof, and nucleic acids which are effectively homologous to disclosed cDNAs, and/or which are capable of coding for mammalian IL-4s and their muteins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.